707 SP 7.5
Generic Name: moexipril
Pill imprint 707 SP 7.5 has been identified as Univasc 7.5 mg.
Univasc is used in the treatment of diabetic kidney disease; high blood pressure; left ventricular dysfunction; heart failure; heart attack and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy.
Univasc 7.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Univasc Images
- Generic Name:
- moexipril
- Imprint:
-
707
SP 7.5 - Strength:
- 7.5 mg
- Color:
- Pink
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose
magnesium oxide
crospovidone
magnesium stearate
gelatin
hydroxypropyl cellulose
hypromellose
polyethylene glycol 6000
titanium dioxide
ferric oxide red
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Schwarz Pharma
- National Drug Code (NDC):
- 00091-3707
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5423 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Univasc resources
Search Again
